Morgan Lewis

Life Sciences Protecting the Complete Life Cycle

For More Information

Read the Brochure

Life Sciences and Healthcare

New Resource

Healthcare Policy and Reform Resource Center

Life Sciences Deskbook

Compliance Resources

New Resource: Health Industry Transparency Compliance Resource Center

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Honors

LMG Life Sciences’s Healthcare Pricing and Reimbursement Firm of 2013

LMG Life Sciences 2013

  • Antitrust – Highly Recommended
  • Competition and Antitrust – Recommended
  • Corporate – Highly Recommended
  • FDA & Pharmaceutical – Recommended
  • General Patent Litigation – Recommended
  • Government Investigation/Fraud & Abuse – Highly Recommended
  • Healthcare: Pricing & Reimbursement – Recommended
  • Licensing & Collaboration (non-university) – Highly Recommended
  • Life Cycle Firm of the Year
  • Mega-Mergers – Recommended
  • Patent Prosecution – Recommended

Chambers Global 2013

  • Global Life Sciences – Recommended, Band 3

Chambers USA 2014

  • National for Life Sciences – Tier 3
  • Washington, D.C., for Healthcare – Pharmaceutical/Medical Products Regulatory – Tier 3

American Health Lawyers Association (AHLA) 2013

  • Top 20 largest U.S. AHLA firm
  • Largest AHLA firm in Pennsylvania
  • One of the largest firms participating in the AHLA Practice Groups of Labor and Life Sciences

Modern Healthcare 2014

  • Ranked 2nd in the Healthcare Law Firms Survey

PLC Cross-border 2012 Life Sciences Legal Market Review

  • Life Sciences Super League – Ranked 14th of law firms worldwide
  • Life Sciences Regulatory Super League – Ranked 8th of law firms worldwide

PLC Life Sciences Multi-Jurisdictional Guide 2012

United States:

  • Commercial and Partnering – Highly Recommended
  • Competition/Antitrust – Highly Recommended
  • Corporate – Recommended
  • Government Enforcement and Investigations – Highly Recommended
  • Pricing and Reimbursement – Recommended
  • Regulatory – Recommended
  • Regulatory (Medical Devices) – Recommended

England:

  • Regulatory – Highly Recommended

Japan:

  • Corporate and Commercial – Recommended

Clients

17 of the top 20 pharmaceutical companies

8 of the top 20 biotechnology companies

13 of the top 20 medical device companies

11 of the top 20 food/beverage companies

Practice Highlights

Related News

01/26/15 Morgan Lewis Advises Entrepreneurs Amit & Meeta Patel on the Sale of Auden Mckenzie to Actavis
Global law firm Morgan Lewis acted as M&A counsel on the sale of Auden Mckenzie Holdings Ltd to Actavis plc for £306 million. The deal will make Actavis the number one supplier of generic pharmaceuticals in the UK.
01/14/15 Life Sciences Group Of The Year: Morgan Lewis, Law360
Our Life Sciences team's work with Merck & Co. on its consumer products division sale to Bayer AG earned the firm a spot among Law360’s Life Sciences Groups of the Year.
01/02/15 Life Sciences Cases To Watch In 2015, Law360
Life Sciences partner Stephen Paul Mahinka is quoted regarding a case involving a brand-name drug manufacturer’s ability to extend the life of its patent.
View all news

Related Publications

02/20/15 Brazil Bill Implements New Provisions for International Data Transfers
The Bill’s provisions on international data transfers are most relevant to foreign companies that do business in Brazil.
01/28/15 Medical Device Update: FDA Releases General Wellness Products and Device Accessories Guidance Documents
U.S. Food and Drug Administration (FDA or the Agency) announced the availability of two draft guidance documents in the Federal Register: “General Wellness: Policy for Low Risk Devices” (General Wellness Guidance) and “Medical Device Accessories: Defining Accessories and Classification Pathway for New Accessory Types” (Accessories Guidance).
12/23/14 New California Privacy Laws for 2015
California continues to lead the way in passing new or updating existing data protection legislation.
View all publications

Comprising more than 175 partners and counsel located in the United States, Europe, and Asia, Morgan Lewis’s Life Sciences and Healthcare Practice is one of the most comprehensive practices in the world—serving more than 1,100 clients throughout the complete product life cycle and in all facets of industry issues. The strength of our team is supported by more than 50 professionals holding advanced scientific degrees.

Our clients include many of the largest and most successful pharmaceutical companies in the world, as well as a variety of biotechnology companies, medical device manufacturers, nutritional companies, healthcare providers, renowned research and scientific institutions, and life sciences–focused investment banks and venture capital firms. As diverse as they are, these companies share a common need for comprehensive, integrated legal services that address all of the business challenges and opportunities facing the industry.

Our Life Sciences and Healthcare Practice focuses on all important areas, from transactions and litigation to regulatory approvals and compliance and protection of intellectual property, as well as key supporting capabilities, including FDA and healthcare, patents and patent litigation, labor and employment law, Morgan Lewis Resources workplace training and immigration, and antitrust. As a full-service firm with offices in the financial and regulatory centers of importance to the industry globally, we are consistently recognized as an industry leader by Chambers USA, Chambers Global, Modern Healthcare, The Legal 500, and other industry observers.